Open Internet by MindsNet

Risk of US Pharma/Biotech Dependency on Foreign Innovation

The potential shift towards in-licensing assets from China could lead to the US primarily focusing on manufacturing and commercialization, while China and other countries drive innovation in R&D. This scenario raises concerns about the future of US pharma/biotech and its reliance on foreign innovation. The challenge lies in whether the US can maintain its competitive edge in the industry.

Futurism & Emerging Fields, Futures Studies, Futurology